.png){kind=icon}
.png){kind=icon}
Return
Dose-dependent effects of SGLT2 inhibitors on circadian blood pressure in hypertensive patients with diabetes: A systematic review and Bayesian network meta-analysis
.png){kind=icon}
OA
AI
D
K
A
E
K
A
S
A
S
M
H
A
L
C
DOI：10.1016/j.ijcrp.2025.200569.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Objective: The impact of dose variation of Sodium-glucose co-transporter 2 (SGLT2) inhibitors in reducing blood pressure (BP) in patients with diabetes and hypertension remains unclear. Methods: A systematic search up to December 29, 2024 identified randomized trials reporting SGLT2 inhibitor effects on 24-h, daytime, nighttime, and office BP, along with hypoglycemia, urinary tract infections, and volume depletion. Continuous outcomes were synthesized as mean differences and safety outcomes as odds ratios within a Bayesian random-effects network meta-analysis. Dose-response patterns were examined using Bayesian metaregression (Delta DIC), and treatment rankings were derived using SUCRA. Results: Nine RCTs involving 9093 participants were included. SGLT2 inhibitors produced modest reductions across 24-h, daytime, nighttime, and office BP, with the largest numerical effect for empagliflozin 25 mg (SBP -5.93 mm Hg), but no credibly significant differences among agents in head-to-head comparisons. Safety outcomes showed no credibly significant excess risk for hypoglycemia, UTI, or volume depletion, with overall event rates low. Bayesian meta-regression yielded Delta DIC values near zero, indicating no detectable dose-response pattern for either blood pressure or safety outcomes. Conclusion: SGLT2 inhibitors produced modest and consistent reductions in BP, with no evidence of dosedependence or meaningful differences among agents. Safety events were not credibly increased. These findings support their use as adjunctive therapy in patients with diabetes and hypertension.
Keywords:
SGLT2 inhibitors
Hypertension
Diabetes mellitus
Blood pressure
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
I
IF:
2.1
Papers:
98
Citations:
0
Organization
Cited Papers